Olivier Brandicourt has been appointed chairman of the board of management of Bayer HealthCare and member of the Bayer executive council effective Nov. 1. Since March, professor Wolfgang Plischke has led Bayer HealthCare on an interim basis in addition to his existing duties as a Bayer board member.

Brandicourt has 25 years of international experience in the pharmaceutical industry, including executive responsibilities in France, the U.S., Canada and the U.K. He has been a member of the executive leadership team of Pfizer for the last three years. Previously, he was president and general manager of the emerging markets and established products business units. Before that he held senior operational positions as president of the global specialty business unit, and until 2012 he was head of the global primary care business unit. He has held senior regional and country management positions at Pfizer and positions in medical and marketing at Warner-Lambert/Parke-Davis.